Structural components necessary for the antiestrogenic activity of tamoxifen
- 1 January 1989
- journal article
- Published by Elsevier in Journal of Steroid Biochemistry
- Vol. 34 (1-6), 407-411
- https://doi.org/10.1016/0022-4731(89)90117-9
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- The pharmacology and clinical uses of tamoxifenPharmacology & Therapeutics, 1984
- Tricyclic triarylethylene antiestrogens: dibenz[b,f]oxepins, dibenzo[b,f]thiepins, dibenzo[a,e]cyclooctenes, and dibenzo[b,f]thiocinsJournal of Medicinal Chemistry, 1983
- Direct and reversible inhibition of estradiol-stimulated prolactin synthesis by antiestrogens in vitro.Journal of Biological Chemistry, 1983
- An estrogen receptor model to describe the regulation of prolactin synthesis by antiestrogens in vitro.Journal of Biological Chemistry, 1983
- Importance of the alkylaminoethoxy side-chain for the estrogenic and antiestrogenic actions of tamoxifen and trioxifene in the immature rat uterusMolecular and Cellular Endocrinology, 1982
- Antiestrogen basicity-activity relationships: a comparison of the estrogen receptor binding and antiuterotrophic potencies of several analogs of (Z)-1,2-diphenyl-1-[4-[2-(dimethylamino)ethoxy]phenyl]-1-butene (Tamoxifen, Nolvadex) having altered basicityJournal of Medicinal Chemistry, 1982
- A simple, rapid, and sensitive DNA assay procedureAnalytical Biochemistry, 1980
- Establishment and characterization of a cell line of human breast carcinoma originEuropean Journal of Cancer (1965), 1979
- A MONOHYDROXYLATED METABOLITE OF TAMOXIFEN WITH POTENT ANTIOESTROGENIC ACTIVITYJournal of Endocrinology, 1977
- Mammalian Antifertility Agents. III. 1-Aryl-2-phenyl-1,2,3,4-tetrahydro-1-naphthols, 1-Aryl-2-phenyl-3,4-dihydronaphthalenes, and Their Derivatives1Journal of Medicinal Chemistry, 1966